Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login


Public health

Researchers find HPV vaccination provides long-term protection

Vaccination against the high-risk human papilloma virus (HPV) in 16 and 18 year-old teenage girls offers long-lasting protection

Source: Alfred Pasieka / Science Photo Library

New research finds that vaccination against high-risk human papilloma virus (pictured) offers long-lasting protection.

Many countries routinely vaccinate teenage girls against human papilloma virus (HPV) infection. New research published in Deutsches Ärzteblatt International[1] suggests that vaccination against the high-risk HPV types 16 and 18 offers long-lasting protection.

Analysis of 10 randomised controlled trials, involving 46,436 participants, found that vaccination prevented 83% of infections in trials with a short duration of follow-up (median 3 years) and 94% of infections in trials with a long duration of follow-up (median 6 years). Efficacy of vaccination against persistent HPV infection was 90% with short follow-up and 95% with long follow-up.

“Long-term observation does not indicate any loss of antiviral protection after vaccination,” write Yvonne Deleré, from the Robert Koch Institute Berlin, and co-authors.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2014.20066668

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.